This paper outlines the basic strategy to design 'true' peptidomimetics, i.e., nonpeptide compounds that bind to the same receptor site as the parent peptide. Design of highly selective and potent agonist analogs of 8-opioid peptides based on development of the 3D model for the 8-opioid pharmacophore is described. The design employed molecular modeling in combination with synthesis, biological testing, NMR spectroscopy and X-ray studies. The designed compounds were able to bind to 8-opioid receptors with affinities and selectivities comparable to those for DPDPE, a well-known k-selective agonist. They also showed moderate 8-agonistic activity.